Narrative review on the role of immunotherapy in early triple negative breast cancer: unveiling opportunities and overcoming challenges
{{output}}
Background and objective: Triple negative breast cancer (TNBC) represents a highly aggressive breast cancer subtype, historically managed with chemotherapy regimens predominantly involving anthracyclines and taxanes, yielding unf... ...
